TABLE 1.

Top 10 up‐ and down‐regulated LncRNA in severe patients when compared with non‐severe patients

Down‐regulated LncRNAs
ensembl‐ID	logFC	AveExpr	t	P value	adj.P. Val	B	Symbol
ENSG00000229807	−6.573	1.542	−4.149	1.86E‐04	8.42E‐04	0.092	XIST
ENSG00000273160	−4.412	2.669	−11.368	1.13E‐13	8.98E‐12	21.097	AL359962.2
ENSG00000223511	−4.180	0.081	−9.204	3.92E‐11	1.01E‐09	15.290	AL683807.1
ENSG00000223511	−4.180	0.081	−9.204	3.92E‐11	1.01E‐09	15.290	AL683807.1
ENSG00000256427	−4.123	−0.124	−12.225	1.32E‐14	2.31E‐12	23.224	AC010175.1
ENSG00000270069	−4.048	0.240	−10.236	2.24E‐12	9.91E‐11	18.136	MIR222HG
ENSG00000276867	−4.042	−0.337	−12.561	5.82E‐15	1.29E‐12	24.032	AC074050.4
ENSG00000256582	−3.974	0.819	−16.160	2.04E‐18	4.28E‐15	31.836	LINC02390
ENSG00000257242	−3.887	1.620	−14.255	1.15E‐16	9.70E‐14	27.892	LINC01619
ENSG00000230606	−3.704	2.173	−13.267	1.09E‐15	4.42E‐13	25.682	AC092683.1

Up‐regulated LncRNAs
ensembl‐ID	logFC	AveExpr	t	P value	adj.P. Val	B	Symbol
ENSG00000231412	3.729	1.059	5.372	4.36E‐06	2.84E‐05	3.758	AC005392.2
ENSG00000274173	3.469	−0.177	6.338	2.13E‐07	1.95E‐06	6.742	AL035661.1
ENSG00000231535	3.075	0.197	2.531	1.57E‐02	4.25E‐02	‐4.104	LINC00278
ENSG00000273812	2.600	0.558	5.737	1.39E‐06	1.03E‐05	4.883	BX640514.2
ENSG00000283036	2.503	−1.086	5.119	9.59E‐06	5.76E‐05	2.983	LINC01988
ENSG00000275527	2.489	0.588	5.922	7.81E‐07	6.16E‐06	5.456	AC100835.2
ENSG00000261172	2.363	0.503	5.143	8.92E‐06	5.39E‐05	3.055	AC133919.2
ENSG00000237520	2.354	−1.232	4.332	1.07E‐04	5.16E‐04	0.623	AL391832.1
ENSG00000226012	2.285	0.014	5.042	1.22E‐05	7.24E‐05	2.747	AP001434.1
ENSG00000249790	2.203	6.121	5.060	1.15E‐05	6.85E‐05	2.804	AC092490.1